Gress Todd, Miller Mark, Meadows Charles, Neitch Shirley M
Internal Medicine, Joan C. Edwards School of Medicine, Marshall University, Huntington, USA.
Psychiatry, West Virginia University School of Medicine, Morgantown, USA.
Cureus. 2020 Oct 19;12(10):e11042. doi: 10.7759/cureus.11042.
Objective To determine the prevalence of benzodiazepine use in adults aged 65 and older at two West Virginia academic medical centers as phase one of a benzodiazepine deprescribing strategy. Design Cross-sectional Setting Two academic hospitals in West Virginia with 107,504 hospitalized adults age 65 and older from the years 2010 to 2018 with information on admission medication use. Measurements Use of benzodiazepines based on presence on the admission medication list. Demographics, select co-morbidities, and laboratory tests were also recorded. Results The prevalence of benzodiazepine use was 13.5% and use remained relatively constant with increasing age over 65, even in those over age 89. Conclusion Efforts aimed at assessing the true need for benzodiazepine use and deprescribing need to be employed, particularly with advancing age.
目的 作为苯二氮䓬类药物减药策略的第一阶段,确定西弗吉尼亚州两家学术医疗中心65岁及以上成年人中苯二氮䓬类药物的使用情况。设计 横断面研究。背景 西弗吉尼亚州的两家学术医院,对2010年至2018年期间107,504名65岁及以上住院成年人的入院用药信息进行研究。测量 根据入院用药清单中是否存在苯二氮䓬类药物来确定其使用情况。还记录了人口统计学、选定的合并症和实验室检查结果。结果 苯二氮䓬类药物的使用率为13.5%,且随着年龄超过65岁,其使用率相对保持稳定,即使在89岁以上的人群中也是如此。结论 需要努力评估使用苯二氮䓬类药物的真正需求并进行减药,尤其是随着年龄的增长。